BAYER PUBLIC LIMITED COMPANY: UK Public Sector Contracts Won & Awards
Large organisation·Newbury·South East England·Main market: Pharmaceutical products
Official UK PPONPWRY-2527-LDRY
Where they win
119 lot-level observations (60 awarded lots, 50%, plus 59 envelope awards without lot links; pending awards included) · top CPV classes
3360 Pharmaceutical products51 observations · 46% · 19 lots + 32 envelope5042 Repair and maintenance services of medical and surgical equipment13 observations · 12% · lots5000 Repair and maintenance services11 observations · 10% · lots3369 Various medicinal products15 observations · 14% · 5 lots + 10 envelope3310 Medical equipments3 observations · 3% · lots3314 Medical consumables3 observations · 3% · lots5080 Miscellaneous repair and maintenance services2 observations · 2% · lots3300 Medical equipments, pharmaceuticals and personal care products13 observations · 12% · 1 lots + 12 envelope| Largest published awards | Authority | Awarded | Term | Published value |
|---|---|---|---|---|
| NP92520b Aflibercept (Eylea®) | The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | — | — | £164,134,486 † |
| Proprietary Drugs | eTenderwales | — | — | £46,964,600 † |
| Proprietary Drugs | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | — | — | £26,379,199 † |
| Aflibercept Pre-filled Syringe 2mg | Belfast Health & Social Care Trust | — | — | £10,000,000 † |
| Aflibercept Pre-filled Syringe | Belfast Health & Social Care Trust | — | — | £7,450,000 † |
Where they deliver
ITL1 delivery regions on the notice · 83 of 93 awarded procedures publish one · a procedure with several regions counts in each
Bidding record
Procurement Act 2023 award notices name every bidder · 2 notices name this supplier since 6 Oct 2025 · observed bids, not an estimate
| Notice | Authority | Outcome | Bids on notice | Published |
|---|---|---|---|---|
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 | NHS England | appointed | 25 | 21 Jul 2026 |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 | NHS England | appointed | 17 | 6 Oct 2025 |
Source: bids.details[].tenderers on Procurement Act 2023 notices (from 2025). PCR 2015 notices name no bidders, so earlier contests are invisible here. Latest ten notices shown.
Who they sell to
Authorities named on this supplier’s published awards · ranked by distinct procedures · award records explode on framework and DPS panels
- NHS & health 61% (73 awards)
- Central government 29% (35 awards)
- Type not classified 8% (10 awards)
- Other public body 1% (1 awards)
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 17 | 18.3% | 25 | 21 Jul 2026 |
| Belfast Health & Social Care Trust | 11 | 11.8% | 11 | 19 Jun 2026 |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | 7 | 7.5% | 7 | 6 Feb 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 5 | 5.4% | 10 | 18 Dec 2023 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | 4 | 4.3% | 7 | 27 Jun 2024 |
| Western Health & Social Care Trust | 4 | 4.3% | 4 | 3 Sept 2026 |
| Leeds Teaching Hospitals NHS Trust | 4 | 4.3% | 4 | 18 Sept 2026 |
| The NHS Commissioning Board (operating under the name of NHS England) | 3 | 3.2% | 4 | 1 Mar 2022 |
Share = of the 93 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts ending
Published end dates only · 31 of 118 awards carry one · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Contrast Injector Pumps | 14 Nov 2026 | £25,937 |
| Maintenance of medical equipment | 31 Mar 2027 | £10,000 |
| Lot 1 - CM/PHS/25/5728/01 | 31 May 2027 | £688,834,174 |
| Lot 2 - CM/PHS/25/5728/02 | 31 May 2027 | £782,917,972 |
| Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo) | 30 Dec 2027 | £105,600 |
| Maintenance of Bayer Injection Systems | 29 Feb 2028 | £400,000 |
Recent awards
Latest 30 of 118 award records naming this supplier
Data coverage & method
- Source: Find a Tender OCDS award and contract releases. An award record is one award × this supplier; a procedure can carry many (panels, call-offs).
- Market observations are awarded lots, or one envelope award when the notice publishes no lot links. Region = delivery ITL1 on the notice, not the supplier’s registered address.
- Authority type: official OCDS UK contracting-authority type when the notice publishes one; otherwise a Tenderline name/id class; otherwise “not classified”. Purchasing hubs with no published type stay unclassified.
- Published value attributable to this supplier alone: £273m across single-supplier awards, framework / DPS ceilings excluded. Coverage is partial and the figure is not turnover, so it is not shown as a headline.
- Contract end dates: published on 31 of 118 awards; 6 end within 18 months.
- Never shown: contact details, reliability or payment scores, affiliations, predicted wins.
Identifiers consolidated into this page (36 historical Find a Tender publication identifiers)
Official notices referenced this supplier under these publication identifiers. Alias URLs are not separate pages.
+12 further identifiers not listed here.
Canonical page id: GB-PPON:PWRY-2527-LDRY